Evercore ISI analyst Liisa Bayko reiterated an Outperform rating and $25.00 price target on Altimmune (NASDAQ: ALT).The analyst comments "Stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE